Willie M Abel1, Lauren N Scanlan, Carolyn E Horne, Patricia B Crane. 1. Willie M. Abel, PhD Associate Professor, School of Nursing, The University of North Carolina at Charlotte. Lauren N. Scanlan, PhDc MA, Department of Psychology, East Carolina University, Greenville, NC. Carolyn E. Horne, PhD Assistant Professor, College of Nursing, East Carolina University, Greenville, NC. Patricia B. Crane, PhD Professor, Carol Grotnes Belk Distinguished Professor, School of Nursing, The University of North Carolina at Charlotte.
Abstract
BACKGROUND: As recurrent myocardial infarctions (MIRs) constitute almost a third of the annual incidence of myocardial infarction, identifying the traditional and novel variables related to MIR is important. OBJECTIVE: The aim of this study was to examine modifiable cardiac risks, adiposity, symptoms associated with inflammation (fatigue, depression, sleep) and inflammatory cytokines, and MIR by sex and race. METHODS: Using a cross-sectional descriptive design, we recruited a convenience sample of adults (N = 156) discharged with first myocardial infarction or had MIR in the last 3 to 7 years. Surveys measured demographics, cardiac risk factors, depression, sleep, and fatigue. Anthropometric measures and cytokines tumor necrosis factor-α, interleukin-6, and high-sensitivity C-reactive protein (hsCRP) were obtained. A maximum likelihood regression was calculated to predict MIR. RESULTS: The sample included 57% male and 30% Black participants, and the mean (SD) age was 65 (12) years. The hsCRP was the only cytokine related to symptoms: fatigue (r = 0.309, P < .001) and depression (r = 0.255, P = .002). An MIR was not associated with race despite White participants reporting better sleep (t146 = -3.25, P = .002), lower body mass index (t154 = -3.49, P = .001), and fewer modifiable risk factors (t152 = -2.05, P = .04). An MIR was associated with being male, higher hsCRP and tumor necrosis factor-α levels (P < .001), and higher inflammatory symptoms of fatigue (P = .04), depression (P = .01), and poor sleep (P < .001). CONCLUSION: Further examination of biomarkers to understand the mechanisms associated with inflammatory symptoms of fatigue, depression, and poor sleep and MIR is needed.
BACKGROUND: As recurrent myocardial infarctions (MIRs) constitute almost a third of the annual incidence of myocardial infarction, identifying the traditional and novel variables related to MIR is important. OBJECTIVE: The aim of this study was to examine modifiable cardiac risks, adiposity, symptoms associated with inflammation (fatigue, depression, sleep) and inflammatory cytokines, and MIR by sex and race. METHODS: Using a cross-sectional descriptive design, we recruited a convenience sample of adults (N = 156) discharged with first myocardial infarction or had MIR in the last 3 to 7 years. Surveys measured demographics, cardiac risk factors, depression, sleep, and fatigue. Anthropometric measures and cytokines tumor necrosis factor-α, interleukin-6, and high-sensitivity C-reactive protein (hsCRP) were obtained. A maximum likelihood regression was calculated to predict MIR. RESULTS: The sample included 57% male and 30% Black participants, and the mean (SD) age was 65 (12) years. The hsCRP was the only cytokine related to symptoms: fatigue (r = 0.309, P < .001) and depression (r = 0.255, P = .002). An MIR was not associated with race despite White participants reporting better sleep (t146 = -3.25, P = .002), lower body mass index (t154 = -3.49, P = .001), and fewer modifiable risk factors (t152 = -2.05, P = .04). An MIR was associated with being male, higher hsCRP and tumor necrosis factor-α levels (P < .001), and higher inflammatory symptoms of fatigue (P = .04), depression (P = .01), and poor sleep (P < .001). CONCLUSION: Further examination of biomarkers to understand the mechanisms associated with inflammatory symptoms of fatigue, depression, and poor sleep and MIR is needed.
Authors: Gregory E Miller; Cinnamon A Stetler; Robert M Carney; Kenneth E Freedland; William A Banks Journal: Am J Cardiol Date: 2002-12-15 Impact factor: 2.778
Authors: A Meijer; H J Conradi; E H Bos; M Anselmino; R M Carney; J Denollet; F Doyle; K E Freedland; S L Grace; S H Hosseini; D A Lane; L Pilote; K Parakh; C Rafanelli; H Sato; R P Steeds; C Welin; P de Jonge Journal: Br J Psychiatry Date: 2013-08 Impact factor: 9.319
Authors: Hyong Jin Cho; Teresa E Seeman; Catarina I Kiefe; Diane S Lauderdale; Michael R Irwin Journal: Brain Behav Immun Date: 2015-02-28 Impact factor: 7.217
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: R Nicholas Carleton; Michel A Thibodeau; Michelle J N Teale; Patrick G Welch; Murray P Abrams; Thomas Robinson; Gordon J G Asmundson Journal: PLoS One Date: 2013-03-01 Impact factor: 3.240